Gracell Biotechnologies Inc. (GRCL): Price and Financial Metrics
GRCL Price/Volume Stats
| Current price | $10.25 | 52-week high | $10.44 |
| Prev. close | $10.24 | 52-week low | $1.40 |
| Day low | $10.17 | Volume | 6,417,100 |
| Day high | $10.28 | Avg. volume | 1,315,803 |
| 50-day MA | $9.13 | Dividend yield | N/A |
| 200-day MA | $5.01 | Market Cap | 744.95M |
GRCL Stock Price Chart Interactive Chart >
Gracell Biotechnologies Inc. (GRCL) Company Bio
Gracell Biotechnologies Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on discovering and developing cell therapies to address medical needs in the treatment of cancer. Gracell Biotechnologies aims to disrupt conventional approaches to CAR-T cell therapies with technology platforms-FasTCAR and TruUCAR.
GRCL Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 93.40% |
| 3-year | 60.66% |
| 5-year | N/A |
| YTD | 2.09% |
| 2023 | 336.52% |
| 2022 | -61.92% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...